EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nonsteroidal Anti‐Inflammatory Drugs and Experimental Chagas Disease: An Unsolved Question

Scheila Thaís Nicolau, Daniela Patrícia Tres, Thaís Soprani Ayala iD, Rafael Andrade Menolli iD

Parasite Immunology · 2024

DOI: 10.1111/pim.13057 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Parasite Immunology, 2024. Verfasst von Scheila Thaís Nicolau und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Immunology, Center of Medical and Pharmaceutical Sciences, Western Parana State University, Cascavel, Brazil. Hauptthemen laut MEDLINE: Chagas Disease, Anti-Inflammatory Agents, Non-Steroidal, Disease Models, Animal, Trypanosoma cruzi. Die Arbeit nennt 68 Literaturangaben. Gefördert von: CAPES, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chagas disease is a parasitic disease caused by the protozoan Trypanosoma cruzi with an acute, detectable blood parasites phase and a chronic phase, in which the parasitemia is not observable, but cardiac and gastrointestinal consequences are possible. Mice are the principal host used in experimental Chagas disease but reproduce the human infection depending on the animal and parasite strain, besides dose and route of administration. Lipidic mediators are tremendously involved in the pathogenesis of T. cruzi infection, meaning the prostaglandins and thromboxane, which participate in the immunosuppression characteristic of the acute phase. Thus, the eicosanoids inhibition caused by the nonsteroidal anti‐inflammatory drugs (NSAIDs) alters the dynamic of the disease in the experimental models, both in vitro and in vivo, which can explain the participation of the different mediators in infection. However, marked differences are founded in the various NSAIDs existing because of the varied routes blocked by the drugs. So, knowing the results in the experimental models of Chagas disease with or without the NSAIDs helps comprehend the pathogenesis of this infection, which still needs a better understanding.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chagas DiseaseAnti-Inflammatory Agents, Non-SteroidalDisease Models, AnimalTrypanosoma cruziAnimalsMiceHumans

Stichwörter der Autor:innen

NSAIDsTrypanosoma cruzi infectionimmunosuppressionlipidic mediatorsparasitemia

Substanzen

Anti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Laboratory of Applied Immunology, Center of Medical and Pharmaceutical Sciences, Western Parana State University, Cascavel, Brazil.

ORCID-Profile: Thaís Soprani Ayala, Rafael Andrade Menolli

Förderung

  • CAPES
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Nicolau, S. T., Tres, D. P., Ayala, T. S., & Menolli, R. A. (2024). Nonsteroidal Anti‐Inflammatory Drugs and Experimental Chagas Disease: An Unsolved Question. Parasite Immunology. https://doi.org/10.1111/pim.13057

Vancouver

Nicolau ST, Tres DP, Ayala TS, Menolli RA. Nonsteroidal Anti‐Inflammatory Drugs and Experimental Chagas Disease: An Unsolved Question. Parasite Immunology. 2024. doi:10.1111/pim.13057

BibTeX
@article{Nicolau2024,
  author = {Nicolau, Scheila Thaís and Tres, Daniela Patrícia and Ayala, Thaís Soprani and Menolli, Rafael Andrade},
  title = {Nonsteroidal Anti‐Inflammatory Drugs and Experimental Chagas Disease: An Unsolved Question},
  journal = {Parasite Immunology},
  year = {2024},
  doi = {10.1111/pim.13057}
}
Kostenlos starten →